Vicora offers treatment of numerous vascular illnesses, including pulmonary embolism, deep vein thrombosis.
Vicora has raised $3.4M in total funding. The most recent round was Seed. The last funding was announced in May 2025.
Vicora's investors include S2 Ventures Partners, Egret Healthcare Ventures.
Vicora is headquartered in Buffalo, United States.
Vicora offers treatment of numerous vascular illnesses, including pulmonary embolism, deep vein thrombosis.
Vicora is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Vicora — Funding & Investors." VCBacked, May 9, 2025, https://www.vcbacked.co/company/vicora. Accessed August 14, 2026.
VCBacked. (2025). Vicora — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/vicora
{{cite web |title=Vicora — Funding & Investors |url=https://www.vcbacked.co/company/vicora |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated